Table 1.
Study participant characteristics
| Total (n=98) | Metabolic Syndrome Absent (n=50) |
Metabolic Syndrome Present (n=48) |
||||||
|---|---|---|---|---|---|---|---|---|
| Number of components | 0 (n=6) | 1 (n=14) | 2 (n=30) | 3 (n=30) | 4 (n=14) | 5 (n=4) | P-Value | |
| Age (years) | 44.7±1.3 | 27.8±2.1 | 34.4±2.8 | 43.7±2.4 | 50.5±1.6 | 51.2±1.8 | 46.7±6.5 | <0.001 |
| Female (%) | 56(57%) | 2(33%) | 7(50%) | 19(63%) | 18(60%) | 8(57%) | 2(50%) | 0.82 |
| Race | 0.22 | |||||||
| Caucasian (%) | 74(76%) | 4(67%) | 12(85.7%) | 20(67%) | 23(77%) | 12(86%) | 3(75%) | |
| African American (%) | 24(24%) | 2(33%) | 2(14.3%) | 10(33%) | 7(23%) | 2(14%) | 1 (25%) | |
| Body Mass Index (kg/m2) | 33.8±0.7 | 25.3±1.3 | 27.7±1.2 | 34.8±1.5 | 35.6±1.0 | 36.9±1.5 | 36.6±2.0 | <0.001 |
| Waist Circumference (cm) | 109.3±1.6 | 86.4±4.4 | 96.0±3.8 | 110.4±2.8 | 113.0±2.1 | 119.2±2.5 | 119.1±3.6 | <0.001 |
| Blood pressure (mmHg) | ||||||||
| Systolic | 124±2 | 113±3 | 111±4 | 120±2 | 129±3 | 136±5 | 144±8 | <0.001 |
| Diastolic | 72±1 | 64±1 | 66±3 | 69±1 | 76±2 | 78±3 | 82±4 | <0.001 |
| Heart Rate (bpm) | 65±1 | 55±4 | 60±3 | 64±2 | 66±2 | 70±4 | 70±4 | 0.007 |
| Total Cholesterol (mM) | 4.56±0.09 | 3.92±0.30 | 4.10±0.16 | 4.66±0.17 | 4.69±0.18 | 4.61±0.25 | 5.02±0.34 | 0.12 |
| Triglycerides (mM) | 1.31±0.11 | 0.51±0.09 | 0.69±0.11 | 1.01±0.07 | 1.41±0.13 | 1.81±0.31 | 4.38±1.10 | <0.001 |
| HDL (mM) | 1.17±0.04 | 1.44±0.10 | 1.58±0.16 | 1.16±0.05 | 1.08±0.04 | 0.96±0.04 | 0.87±0.06 | <0.001 |
| LDL (mM) | 2.81±0.09 | 2.24±0.33 | 2.21±0.16 | 3.04±0.16 | 2.97±0.16 | 2.87±0.24 | 2.5±0.45 | 0.38 |
| Body Fat (%) | 35.0±1.3 | 18.3±2.9 | 23.7±3.9 | 37.0±2.3 | 39.0±1.7 | 40.5±2.8 | 37.9±6.3 | 0.002 |
| Fasting glucose (mM) | 5.6±0.1 | 5.0±0.2 | 5.3±0.1 | 5.3±0.1 | 5.7±0.1 | 6.1±0.3 | 6.5±0.4 | <0.001 |
*P-value indicates comparison between those with versus without metabolic syndrome. HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol